Serstech
Serstech receives 4.2 MSEK order from India
Serstech receives 4.2 MSEK order from India
Serstech has today received a 4.2 MSEK order from its Indian partner, Kapri Corp. The order includes the Serstech Arx mkII and related software and will be delivered and invoiced in Q1 2026.
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB Phone: +46 739 606 067
Email: ss@serstech.com
or
Thomas Pileby,
Chairman of the Board, Serstech AB Phone: +46 702 072 643
Email: tp@serstech.com
or visit: www.serstech.com
This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 12:35 CET on December 10, 2025.
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).
About Serstech
Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.
Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ProMIS Neurosciences Inc.10.12.2025 13:30:00 CET | Press release
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
Tallink Grupp10.12.2025 13:30:00 CET | Press release
AS Tallink Grupp: Managers’ Transactions
Scatec ASA10.12.2025 13:26:22 CET | Press release
Scatec starts commercial operation at Mmadinare phase 2 in Botswana
Karolinska Development AB (publ)10.12.2025 13:05:37 CET | Press release
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia
Nykredit Realkredit A/S10.12.2025 12:51:58 CET | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom